首页> 外文期刊>Pharmacology and Therapeutics: The Journal of the International Encyclopedia of Pharmacology and Therapeutics >A deep dive into UV-based phototherapy: Mechanisms of action and emerging molecular targets in inflammation and cancer
【24h】

A deep dive into UV-based phototherapy: Mechanisms of action and emerging molecular targets in inflammation and cancer

机译:深入潜水到紫外线的光疗法:炎症和癌症中的作用机制和新兴分子靶标

获取原文
获取原文并翻译 | 示例
           

摘要

UV-based phototherapy (including psoralen plus UVA (PUVA), UVB and UVA1) has a long, successful history in the management of numerous cutaneous disorders. Photoresponsive diseases are etiologically diverse, but most involve disturbances in local (and occasionally systemic) inflammatory cells and/or abnormalities in keratinocytes that trigger inflammation. UV-based phototherapy works by regulating the inflammatory compo-nent and inducing apoptosis of pathogenic cells. This results in a fascinating and complex network of simulta-neous events-immediate transcriptional changes in keratinocytes, immune cells, and pigment cells; the emergence of apoptotic bodies; and the trafficking of antigen-presenting cells in skin-that quickly transform the microenvironment of UV-exposed skin. Molecular elements in this system of UV recognition and response include chromophores, metabolic byproducts, innate immune receptors, neurotransmitters and mediators such as chemokines and cytokines, antimicrobial peptides, and platelet activating factor (PAF) and PAF-like mol-ecules that simultaneously shape the immunomodulatory effects of UV and their interplay with the microbiota of the skin and beyond. Phototherapy's key effects-proapoptotic, immunomodulatory, antipruritic, antifibrotic, propigmentary, and pro-prebiotic-promote clinical improvement in various skin diseases such as psoriasis, atopic dermatitis (AD), graft-versus-host disease (GvHD), vitiligo, scleroderma, and cutaneous T-cell lymphoma (CTCL) as well as prevention of polymorphic light eruption (PLE). As understanding of phototherapy improves, new therapies (UV-and non-UV-based) are being developed that will modify regulatory T-cells (Treg), interact with (resident) memory T-cells and /or utilize agonists and antagonists as well as antibodies targeting soluble molecules such as cytokines and chemokines, transcription factors, and a variety of membrane-associated receptors. (C) 2020 Elsevier Inc. All rights reserved.
机译:基于紫外线的光疗(包括补骨脂素加UVA(PUVA)、UVB和UVA1)在许多皮肤疾病的治疗中有着悠久而成功的历史。光反应性疾病的病因多种多样,但大多数涉及局部(偶尔包括全身)炎症细胞的紊乱和/或触发炎症的角质形成细胞的异常。基于紫外线的光疗通过调节炎症成分和诱导致病细胞凋亡发挥作用。这导致角质形成细胞、免疫细胞和色素细胞的即时转录变化,形成一个迷人而复杂的同时事件网络;凋亡小体的出现;以及抗原呈递细胞在皮肤中的运输,这些细胞能迅速改变紫外线暴露皮肤的微环境。紫外线识别和响应系统中的分子元素包括发色团、代谢副产物、固有免疫受体、神经递质和介质,如趋化因子和细胞因子、抗菌肽、,以及血小板激活因子(PAF)和PAF样分子微粒,它们同时形成紫外线的免疫调节效应及其与皮肤内外微生物群的相互作用。光疗法的关键作用是促凋亡、免疫调节、止痒、抗纤维化、促节段性和亲益生元,可促进各种皮肤疾病的临床改善,如银屑病、特应性皮炎(AD)、移植物抗宿主病(GvHD)、白癜风、硬皮病和皮肤T细胞淋巴瘤(CTCL)以及多形性光疹(PLE)的预防。随着对光疗的理解提高,正在开发新的疗法(紫外线和非紫外线疗法),它们将修饰调节性T细胞(Treg),与(驻留的)记忆性T细胞相互作用,和/或利用激动剂和拮抗剂以及针对可溶性分子的抗体,如细胞因子和趋化因子、转录因子和各种膜相关受体。(C) 2020爱思唯尔公司版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号